Today: 9 April 2026
Intel stock price jumps to $50: China CPU delays and SambaNova funding set up week ahead
8 February 2026
2 mins read

Intel stock price jumps to $50: China CPU delays and SambaNova funding set up week ahead

New York, Feb 7, 2026, 19:16 EST — The market has closed.

Intel shares finished Friday’s session 4.9% higher at $50.59, giving the stock some momentum heading into a new week, as two recent company-related headlines loom. After the bell, the price barely budged. Yahoo Finance

Chip stocks roared back, shrugging off recent weakness as bets on AI-driven data-center spending picked up again. Amazon and Alphabet flagged bigger capital expenditures—more money flowing into gear and infrastructure—which helped power the rebound. The PHLX semiconductor index jumped 5.7%. “There’s real demand for AI products,” noted Ross Mayfield, investment strategy analyst at Baird. Reuters

This is significant for Intel, since the AI push isn’t limited to GPUs — those graphics chips that handle much of the training. Servers still require CPUs, the workhorse processors for regular computing, and investors are watching closely for evidence that “traditional compute” demand could outperform expectations.

Before U.S. markets got going, Reuters reported that Intel and Advanced Micro Devices had notified Chinese customers of tighter server CPU supply, citing sources familiar with the delays. Intel’s delivery lead times are stretching out to as long as six months. That squeeze has lifted Intel’s server CPU prices in China by more than 10%, the report said. China pulls in over 20% of Intel’s total revenue. According to Intel, surging AI demand is fueling appetite for “traditional compute.” The company expects supply to get better in the second quarter. Reuters

After the close, news broke that Vista Equity Partners is fronting a fresh funding round for AI chipmaker SambaNova Systems — more than $350 million on the table, according to Reuters. Intel, already an investor, is looking to chip in about $100 million, with a possible bump up to $150 million, sources told Reuters. SambaNova’s specialty: “inference” chips, which power AI models after they’re trained. None of the parties — Intel, Vista, or SambaNova — offered any comment, and Reuters noted the deal terms aren’t set in stone. Reuters

Put together, these stories show the AI surge is rippling through the supply chain—CPUs, memory, and other server parts—not just the accelerators where Nvidia leads. For Intel, it’s another reminder: deliver on targets, keep AMD at bay, and convince investors there’s a real AI hardware plan outside its bread-and-butter business.

The setup isn’t straightforward. Extended delivery times might support prices for now, but they also open the door for customers to scout out other options, delay upgrades, or negotiate deals that could bite into margins down the line. That late-stage funding round? It’s not a done deal until the paperwork’s signed and the money actually shows up.

Macro events could easily steal the spotlight from company news. The U.S. Labor Department’s jobs report for January lands Feb. 11, with the January CPI inflation numbers following on Feb. 13 at 8:30 a.m. Eastern. Both reports have a track record of jolting rate expectations—which tends to ripple through to risk-on plays like tech and chip stocks. Bureau of Labor Statistics

Monday’s session will test if Intel can keep Friday’s momentum, as traders weigh China’s CPU supply issues, the SambaNova investment headlines, and fresh U.S. numbers. The February 13 inflation data stands out as the next scheduled catalyst.

Stock Market Today

  • CONMED Stock Analysis: Growth Outlook and Market Challenges
    April 9, 2026, 1:16 PM EDT. CONMED Corporation (CNMD) shows promising growth potential driven by its diverse surgical product range and strength in General Surgery, including the AirSeal insufflator and Anchor Tissue Retrieval bag. The company projects 19.3% earnings growth for fiscal 2025, maintaining solid performance with an average earnings surprise of 3.71%. Despite a 3.3% stock decline over six months, lagging the S&P 500's 14.3% rise, CNMD remains competitive amid supply chain and data security challenges. The recent 3.6% revenue gain in General Surgery and strategic acquisition of In2Bones Global underscore its growth strategy. However, U.S. sales in the foot and ankle segment may face short-term setbacks due to hurricane disruptions. Investors should weigh these factors when considering CONMED stock retention.

Latest article

Amazon Stock Rises After Andy Jassy Reveals AWS AI Revenue, Defends $200 Billion Spend

Amazon Stock Rises After Andy Jassy Reveals AWS AI Revenue, Defends $200 Billion Spend

9 April 2026
Amazon shares rose 5% Thursday after CEO Andy Jassy revealed AWS’s AI services are generating over $15 billion annually and its chip business more than $20 billion. Jassy said much of AWS’s $200 billion in planned 2026 spending is backed by customer commitments, including a $100 billion OpenAI deal. He also highlighted deep job cuts and a push for smaller teams. Amazon now operates over 1 million robots and plans to launch its Leo satellite network in mid-2026.
Unilever Snaps Up Grüns to Deepen U.S. Wellness Push After McCormick Food Deal

Unilever Snaps Up Grüns to Deepen U.S. Wellness Push After McCormick Food Deal

9 April 2026
Unilever said Thursday it will acquire U.S. greens-supplement brand Grüns for an undisclosed sum, with the deal expected to close later this year pending approvals. Grüns was valued at about $500 million in a 2025 Series B round, according to Reuters. The purchase follows Unilever’s recent agreement to combine its food business with McCormick.
Lumentum Stock Nears $960 After JPMorgan, Mizuho Raise Targets on Nvidia AI Optics Demand

Lumentum Stock Nears $960 After JPMorgan, Mizuho Raise Targets on Nvidia AI Optics Demand

9 April 2026
Lumentum shares climbed Thursday after JPMorgan raised its price target to $950, following Mizuho’s hike to $930. The moves come after Nvidia agreed last month to invest $2 billion in Lumentum and make multibillion-dollar purchase commitments. Lumentum reported February quarter revenue of $665.5 million, up 65.5% year-over-year. An SEC filing showed Lumentum will swap 5.7 million shares for $474.6 million in convertible notes.
SBTi Says Corporate Climate Targets Jumped 40% in 2025 as Asia Closes In on Europe

SBTi Says Corporate Climate Targets Jumped 40% in 2025 as Asia Closes In on Europe

9 April 2026
The number of companies with Science Based Targets initiative-validated climate goals reached 9,764 by the end of 2025, up 40% from the previous year. Asia added 1,216 companies, nearly matching Europe’s increase. Europe held 49% of validated targets, Asia 36%, and North America 11%. Japan led single markets with 2,091 companies.
Palantir Stock Drops as Michael Burry Says Anthropic Is ‘Eating Its Lunch’

Palantir Stock Drops as Michael Burry Says Anthropic Is ‘Eating Its Lunch’

9 April 2026
Palantir Technologies dropped about 7% Thursday after Michael Burry said Anthropic was overtaking it in enterprise AI, putting Palantir on track to lose $34 billion in market value. Anthropic reported its annualized revenue run rate had surged past $30 billion and launched new AI tools for businesses. Nearly one in four businesses on Ramp now pays for Anthropic, according to Ramp data. Palantir’s stock still trades at 395 times earnings.
SK hynix stock price slips to 839,000 won as Korea tech selloff bites — what to watch next week
Previous Story

SK hynix stock price slips to 839,000 won as Korea tech selloff bites — what to watch next week

AMD stock bounces 8% after brutal midweek slide — what investors watch before Monday
Next Story

AMD stock bounces 8% after brutal midweek slide — what investors watch before Monday

Go toTop